Healthcare of Ontario Pension Plan Trust Fund Invests $6.76 Million in Celanese Corporation $CE

Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Celanese Corporation (NYSE:CE) during the first quarter, HoldingsChannel.com reports. The firm purchased 102,800 shares of the basic materials company’s stock, valued at approximately $6,761,000.

Several other large investors have also recently bought and sold shares of the business. Capital Research Global Investors grew its stake in shares of Celanese by 24.0% during the 4th quarter. Capital Research Global Investors now owns 5,565,556 shares of the basic materials company’s stock worth $235,312,000 after purchasing an additional 1,076,645 shares during the period. Hsbc Holdings PLC grew its position in Celanese by 208.3% during the fourth quarter. Hsbc Holdings PLC now owns 105,435 shares of the basic materials company’s stock worth $4,460,000 after buying an additional 71,238 shares during the period. U.S. Capital Wealth Advisors LLC lifted its position in shares of Celanese by 113.1% during the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 152,291 shares of the basic materials company’s stock valued at $6,439,000 after acquiring an additional 80,827 shares during the period. SG Americas Securities LLC boosted its stake in shares of Celanese by 803.0% during the 4th quarter. SG Americas Securities LLC now owns 28,931 shares of the basic materials company’s stock worth $1,223,000 after acquiring an additional 25,727 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Celanese in the 4th quarter worth approximately $20,047,000. Hedge funds and other institutional investors own 98.87% of the company’s stock.

Celanese Stock Performance

Shares of NYSE CE opened at $43.94 on Thursday. The company has a 50-day simple moving average of $49.38 and a 200-day simple moving average of $54.03. The company has a debt-to-equity ratio of 2.41, a current ratio of 1.38 and a quick ratio of 0.85. The company has a market cap of $4.82 billion, a PE ratio of -4.39, a price-to-earnings-growth ratio of 0.27 and a beta of 0.76. Celanese Corporation has a 12 month low of $35.13 and a 12 month high of $70.70.

Celanese (NYSE:CE) last issued its quarterly earnings results on Tuesday, May 5th. The basic materials company reported $0.85 earnings per share for the quarter, missing analysts’ consensus estimates of $0.88 by ($0.03). Celanese had a positive return on equity of 9.92% and a negative net margin of 11.54%.The business had revenue of $2.34 billion for the quarter, compared to analysts’ expectations of $2.34 billion. During the same period in the prior year, the company earned $0.57 EPS. The company’s revenue for the quarter was down 2.2% compared to the same quarter last year. Celanese has set its Q2 2026 guidance at 2.000-2.400 EPS. On average, equities analysts anticipate that Celanese Corporation will post 6.01 earnings per share for the current year.

Celanese Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 10th. Investors of record on Tuesday, July 28th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Tuesday, July 28th. Celanese’s dividend payout ratio is -1.20%.

Analyst Ratings Changes

Several research firms have weighed in on CE. Wells Fargo & Company upped their target price on Celanese from $75.00 to $80.00 and gave the company an “overweight” rating in a report on Friday, May 8th. Wall Street Zen downgraded shares of Celanese from a “buy” rating to a “hold” rating in a report on Saturday, June 20th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $60.00 price target on shares of Celanese in a report on Wednesday, July 22nd. BMO Capital Markets cut their price objective on Celanese from $80.00 to $57.00 and set a “market perform” rating for the company in a research report on Monday, July 6th. Finally, Mizuho reduced their target price on Celanese from $65.00 to $55.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 1st. Ten research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $65.94.

About Celanese

Celanese Corporation is a global chemical and specialty materials company that develops, manufactures and markets a broad portfolio of products serving diverse industries. The company operates through two primary business segments—Engineered Materials and Acetyl Chain—offering solutions that range from high-performance polymers and specialty additives to industrial chemicals and intermediates. Its engineered materials are used in applications such as automotive components, consumer electronics, medical devices and packaging, while its acetyl derivatives find uses in coatings, adhesives, solvents and personal care products.

In the Engineered Materials segment, Celanese produces a variety of high-performance thermoplastics, polyether-block-amide (PEBA) elastomers and functional additives designed to enhance product durability, thermal resistance and sustainability.